Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

22.2%

2 terminated/withdrawn out of 9 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(50.0%)
Phase 4
1(50.0%)
2Total
Phase 3(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT06698406Completed

Transcultural Validation of the French Version of the " Patients' Endorsement of a Biopsychosocial Model of Chronic Pain " Scale

Role: lead

NCT03216187Phase 3Terminated

Swiss Multi-centre, Randomized, Placebo Controlled Trial of Pregabalin for Prevention of Persistent Pain in High Risk Patients Undergoing Breast Cancer Surgery

Role: lead

NCT04565470Completed

Strategies of Self-management of Endometriosis Symptoms

Role: lead

NCT02774694Not Yet Recruiting

Prediction of Outcome of Interventional Pain Management

Role: lead

NCT05307380Completed

Transcultural Validation of the French Version of the Functional Pain Scale "Defense and Veterans Pain Rating Scale"

Role: lead

NCT04144998Completed

Central Sensitization and Outcome of Endometriosis Surgery

Role: lead

NCT03164954Terminated

Observational Study of an Automatic Detection of Patients at Risk of Chronic Postoperative Pain ("Alerte Douleur")

Role: lead

NCT01828424Completed

Prediction of Postoperative Pain by Measuring Nociception at the End of Surgery

Role: lead

NCT01931215Phase 4Completed

Transversus Abdominis Plane (TAP) Block Versus Intrathecal Morphine for Caesarean Section - Randomised Controlled Trial

Role: lead

All 9 trials loaded